Retractable Technologies (RVP) Long-Term Deferred Tax (2020 - 2024)
Retractable Technologies' (RVP) quarterly Long-Term Deferred Tax came in at $8.3 million in Q1 2024, up 32.13% YoY from $6.3 million in Q2 2023, and down 1.0% on a QoQ basis from $8.4 million in Q4 2023.
Retractable Technologies (RVP) Long-Term Deferred Tax (2020 - 2024) Analysis & Trends
Retractable Technologies (RVP) has 5 years of Long-Term Deferred Tax data on file, last reported at $8.3 million in Q1 2024.
- Quarterly Long-Term Deferred Tax rose 32.13% year-over-year to $8.3 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $8.3 million (up 32.13% YoY) and the FY2023 annual result came in at $8.4 million, up 28.74% from the prior year.
- Long-Term Deferred Tax declined to $8.3 million in Q1 2024, from $8.4 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $13.9 million in Q4 2021 to a low of $804357.0 in Q3 2020.
- A 5-year average of $7.8 million and a median of $8.4 million in 2023 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2021 — Long-Term Deferred Tax soared 1534.26% — and 2022, when it slumped 52.99%.
- Tracing RVP's Long-Term Deferred Tax over 5 years: stood at $4.6 million in 2020, then soared by 199.4% to $13.9 million in 2021, then tumbled by 52.99% to $6.5 million in 2022, then grew by 28.74% to $8.4 million in 2023, then slipped by 1.0% to $8.3 million in 2024.
- The last three Long-Term Deferred Tax figures came in at $8.3 million (Q1 2024), $8.4 million (Q4 2023), and $8.5 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Retractable Technologies | 21.67 Mn | -18.20 Mn | 190,852.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 8.31 Mn |
| Dec 31, 2023 | 8.39 Mn |
| Sep 30, 2023 | 8.53 Mn |
| Jun 30, 2023 | 7.22 Mn |
| Mar 31, 2023 | 6.29 Mn |
| Dec 31, 2022 | 6.52 Mn |
| Sep 30, 2022 | 9.97 Mn |
| Jun 30, 2022 | 9.65 Mn |
| Mar 31, 2022 | 8.79 Mn |
| Dec 31, 2021 | 13.87 Mn |
| Sep 30, 2021 | 13.15 Mn |
| Jun 30, 2021 | 11.25 Mn |
| Mar 31, 2021 | 6.37 Mn |
| Dec 31, 2020 | 4.63 Mn |
| Sep 30, 2020 | 804,357.00 |
| Jun 30, 2020 | 1.80 Mn |